• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The N-terminal region of IFITM3 modulates its antiviral activity through regulating IFITM3 cellular localization

tetano

Editor, Senior Moderator
J Virol. 2012 Oct 10. [Epub ahead of print]
The N-terminal region of IFITM3 modulates its antiviral activity through regulating IFITM3 cellular localization.
Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, Qiao W, Liang C.
Source

Key Laboratory of Molecular Microbiology and Biotechnology (Ministry of Education) and Key Laboratory of Microbial Functional Genomics (Tianjin), College of Life Sciences, Nankai University, Tianjin 300071, China.
Abstract

Interferon inducible transmembrane (IFITM) protein family members IFITM1, 2 and 3 restrict the infection of multiple enveloped viruses. Significant enrichment of a minor IFITM3 allele was recently reported in patients who were hospitalized for seasonal and 2009 H1N1 pandemic flu. This IFITM3 allele lacks the first amino-terminal 21 amino acids and is unable to inhibit influenza A virus. In this study, we find that deleting this 21-amino acid region relocates IFITM3 from the endosomal compartments to cell periphery. This finding likely underlies the lost inhibition of influenza A virus that completes its entry exclusively within endosomes at low pH. Yet, both the wild type IFITM3 and the 21 amino acid-deletion mutant inhibit HIV-1 replication equally well. Given the pH-independent nature of HIV-1 entry, our results suggest that IFITM3 can inhibit viruses that enter cells via different routes and that its N-terminal region is specifically required for controlling pH-dependent viruses.

PMID:
23055554
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23055554
 
Back
Top Bottom